Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease
Overview
This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: April 24, 2018
Detailed Description
Advances in surgical and clinical management of patients with congenital heart disease has made survival to adulthood an expectation. Today there are more than 1 million adult survivors of congenital heart disease, but increasing age brings additional concerns for this patient population. Although the literature remains scarce, existing evidence suggests that inactivity, obesity, diabetes, cancer, and acquired cardiovascular disease may be at least as prevalent in patients with congenital heart disease, if not more so, than in an age-matched general population. Acquired cardiovascular disease is likely to impact substantially on long-term survival and quality of life in these patients with palliated and already fragile hearts. This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
Arms, Groups and Cohorts
- Adult Congenital Heart Disease
- 18 years and older with congenital heart disease
Clinical Trial Outcome Measures
Primary Measures
- Risk factors for acquired cardiovascular disease in adults with congenital heart disease
- Time Frame: 2 years
Participating in This Clinical Trial
Inclusion Criteria
- Male or Female over 18 years of age – Moderate or Complex Congenital Heart Disease – Willingness to Consent Exclusion Criteria:
- Pregnancy – Surgery within 6 months – Unrepaired cyanotic heart disease – Patients with Eisenmenger Syndrome physiology
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Stanford University
- Provider of Information About this Clinical Study
- Principal Investigator: Susan Fernandes, Principal Investigator – Stanford University
- Overall Official(s)
- Susan Fernandes, PA-C, LP.D., Principal Investigator, Stanford Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.